Oncentra Brachy radiation therapy planning software… recallZ-1712-2015 · Elekta, Inc. · initiated May 21, 2015
Class II Terminated All recalls posted in June 2015
Is my device affected?
- Compare the model, catalog and lot or serial numbers on your device or its packaging with the code information below. A recall usually covers only specific models or lots.
- If yours is listed, follow the instructions from Elekta, Inc. or your healthcare provider. The company's action is summarized under what the company is doing.
- Do not stop using a prescribed or implanted device on your own — talk to your healthcare provider first.
Where to find your model and lot numbers · What recall classes and statuses mean
Why it was recalled
Incorrect dose calculation for Regions of Interest (ROIs) defined on a secondary image series.
FDA root cause category: Other
What the company is doing
Important User Notice, 806-03-BTP-001, was distributed to customers on 5/21/2015, A software patch is in development and is expected to be released end of November, 2015. Elekta service will work with customers to implement the patch on affected devices within 6 months of the patch release.
Recall details
- Recall number
- Z-1712-2015
- Recall class
- Class II
- Status
- Terminated
- Initiated by the company
- May 21, 2015
- Posted by the FDA
- Jun 4, 2015
- Recalling firm
- Elekta, Inc.
- Quantity
- 351
- Product code
- MUJ
- FDA submissions
- K081281, K121448
- Distribution
- AL, AZ, AR, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MD, MA, MI, MN, MS, MO, MT, NE, NC, NH, NJ, NY, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WV, WI, Argentina, Australia, Bangladesh, Belarus, Botswana, Brazil, Canada, Chile, China, Colombia, Ecuador, Egypt, Guatemala, Hong Kong, India, Indonesia, Israel, Japan, Jordan, Kosovo, Libya, Malaysia, Mexico, Morocco, Namibia, Nepal, New Zealand, Oman, Pakistan, Peru, Philippines, Qatar, Russia, Saudi Arabia, Serbia, Singapore, South Africa, South Korea, Sri Lanka, Suriname, Taiwan, Thailand, Tobago, Ukraine, Venezuela, Vietnam, Zambia
Product description
Oncentra Brachy radiation therapy planning software designed to analyze and plan radiation treatments in three dimensions for the purpose of treating patients with cancer.
Code information (models, lots, serial numbers)
MUJ/892.5050, Software Builds - 3.3, 4.0, 4.1, 4.3
Other devices under the same FDA submission
15 devices cleared under K081281, K121448 — the recall does not name any of them by identifier. One submission often covers many models, so they may or may not be affected.
- NA 170003-28Nucletron B.V. · System,planning,radiation therapy treatment2 recalls2 reports
- NA 170607-00Nucletron B.V. · System, planning, radiation therapy treatment2 recalls1 report
- NA 170730Nucletron B.V. · System,planning,radiation therapy treatment2 recalls0 reports
- NA 170730Nucletron B.V. · System,planning,radiation therapy treatment2 recalls0 reports
- NA 170003-23Nucletron B.V. · System,planning,radiation therapy treatment2 recalls0 reports
- NA 170537-04Nucletron B.V. · System,planning,radiation therapy treatment2 recalls0 reports
- NA 170003-24Nucletron B.V. · System, applicator, radionuclide, remote-controlled2 recalls0 reports
- NA 170537-05Nucletron B.V. · System,planning,radiation therapy treatment2 recalls0 reports
- NA 170003-25Nucletron B.V. · System,planning,radiation therapy treatment2 recalls0 reports
- NA 170537-06Nucletron B.V. · System,planning,radiation therapy treatment2 recalls0 reports
- NA 170003-27Nucletron B.V. · System,planning,radiation therapy treatment2 recalls0 reports
- NA 170537-06Nucletron B.V. · System,planning,radiation therapy treatment2 recalls0 reports
Sources and updates
- Recall record: FDA Medical Device Recalls, file dated Oct 16, 2026 · View the FDA recall notice ↗
- Devices: FDA GUDID, file dated Oct 13, 2026. Devices are linked when their identifier (with a valid check digit) appears in the recall's code information.
- Page last rebuilt: Oct 18, 2026. Text above is shown as published by the FDA.
How recalls are matched to devices · Editorial policy · Report an error on this page